• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . SARS-CoV-2 Blood RNA Load Predicts Outcome in Critically Ill COVID-19 Patients

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2021 Oct 6;8(11):ofab509.
doi: 10.1093/ofid/ofab509. eCollection 2021 Nov.
SARS-CoV-2 Blood RNA Load Predicts Outcome in Critically Ill COVID-19 Patients


Fabian Heinrich[SUP] 1 [/SUP], Michael F Nentwich[SUP] 2 [/SUP], Eric Bibiza-Freiwald[SUP] 1 [/SUP], Dominik Nörz[SUP] 1 [/SUP], Kevin Roedl[SUP] 2 [/SUP], Martin Christner[SUP] 1 [/SUP], Armin Hoffmann[SUP] 1 [/SUP], Flaminia Olearo[SUP] 1 [/SUP], Stefan Kluge[SUP] 2 [/SUP], Martin Aepfelbacher[SUP] 1 [/SUP], Dominic Wichmann[SUP] 2 [/SUP], Marc Lütgehetmann[SUP] 1 [/SUP], Susanne Pfefferle[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in patient specimens may act as a clinical outcome predictor in critically ill patients with coronavirus disease 2019 (COVID-19).
Methods: We evaluated the predictive value of viral RNA loads and courses in the blood compared with the upper and lower respiratory tract loads of critically ill COVID-19 patients. Daily specimen collection and viral RNA quantification by reverse transcription quantitative polymerase chain reaction were performed in all consecutive 170 COVID-19 patients between March 2020 and February 2021 during the entire intensive care unit (ICU) stay (4145 samples analyzed). Patients were grouped according to their 90-day outcome as survivors (n=100) or nonsurvivors (n=70).
Results: In nonsurvivors, blood SARS-CoV-2 RNA loads were significantly higher at the time of admission to the ICU (P=.0009). Failure of blood RNA clearance was observed in 33/50 (66%) of the nonsurvivors compared with 12/64 (19%) survivors (P<.0001). As determined by multivariate analysis, taking sociodemographic and clinical parameters into account, blood SARS-CoV-2 RNA load represents a valid and independent predictor of outcome in critically ill COVID-19 patients (odds ratio [OR; log[SUB]10[/SUB]], 0.23; 95% CI, 0.12-0.42; P<.0001), with a significantly higher effect for survival compared with respiratory tract SARS-CoV-2 RNA loads (OR [log[SUB]10[/SUB]], 0.75; 95% CI, 0.66-0.85; P<.0001). Blood RNA loads exceeding 2.51×103 SARS-CoV-2 RNA copies/mL were found to indicate a 50% probability of death. Consistently, 29/33 (88%) nonsurvivors with failure of virus clearance exceeded this cutoff value constantly.
Conclusions: Blood SARS-CoV-2 load is an important independent outcome predictor and should be further evaluated for treatment allocation and patient monitoring.

Keywords: 2; 2 RNA load; CoV; SARS; kinetics; viremia.
 
Back
Top Bottom